From 2009 to 2013 Professor Jutta Heim was the Chief Scientific Officer of Evolva SA with responsibility for all Synthetic Biology and metabolic engineering work for the production of new or known natural products. Before that position, Dr Heim was Chief Scientific Officer of Basilea Pharmaceutica AG, a Swiss biopharmaceutical company, where she was in charge of all anti-infective, dermatology and oncology discovery activities. Prior to joining Basilea Pharmaceutica, Dr Heim worked for 22 years in Switzerland and the United States for Ciba-Geigy/Novartis, where she was involved in the successful development and launch of biopharmaceuticalanti-thrombotic and fibrinolytic products, initiated a molecular genetics department in oncology and became Novartis’ Senior Scientific Expert in Molecular Biology and a member of the Research Management Board. She is currently the Chair of the GARDP Scientific Advisory Committee, and holds non-executive director positions in several boards. She is titular Professor of Biotechnology at the University of Basel, Switzerland.
Jutta Heim
